BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16956919)

  • 1. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
    Mudter J; Neurath MF
    Gut; 2007 Feb; 56(2):293-303. PubMed ID: 16956919
    [No Abstract]   [Full Text] [Related]  

  • 2. New strategies in the management of inflammatory bowel disease.
    Rutgeerts P; Baert F
    Acta Clin Belg; 1999 Oct; 54(5):274-80. PubMed ID: 10555385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 4. Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
    Ramos JM; García-Sepulcre MF; Masiá M; Brotons A; Grau MC; Gutiérrez F
    Rev Esp Enferm Dig; 2010 Oct; 102(10):614-6. PubMed ID: 21039077
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical therapies for inflammatory bowel disease.
    Stotland BR; Cirigliano MD; Lichtenstein GR
    Hosp Pract (1995); 1998 May; 33(5):141-4, 149-51, 156 passim. PubMed ID: 9606359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
    Chapman CG; Rubin DT
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):353-65. PubMed ID: 24975527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in inflammatory bowel disease therapy.
    Thomson AB; Williams CN
    Can J Gastroenterol; 1999 Nov; 13(9):775-6. PubMed ID: 10633831
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
    Cossu A; Biancone L; Ascolani M; Pallone F; Boirivant M
    J Crohns Colitis; 2013 Jul; 7(6):441-50. PubMed ID: 22840925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
    Geboes K; Desreumaux P; Jouret A; Ectors N; Rutgeerts P; Colombel JF
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1062-73. PubMed ID: 10592879
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
    Atreya R; Atreya I; Neurath MF
    Ann N Y Acad Sci; 2006 Aug; 1072():98-113. PubMed ID: 17057193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis of inflammatory bowel diseases].
    Neurath MF; Schürmann G
    Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
    Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y
    Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.
    Neurath MF; Finotto S; Fuss I; Boirivant M; Galle PR; Strober W
    Trends Immunol; 2001 Jan; 22(1):21-6. PubMed ID: 11286687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving treatment strategies for inflammatory bowel disease.
    Hanauer SB; Dassopoulos T
    Annu Rev Med; 2001; 52():299-318. PubMed ID: 11160781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences.
    Kountouras J; Kouklakis G; Zavos C; Chatzopoulos D; Moschos J; Molyvas E; Zavos N
    Can J Gastroenterol; 2003 Apr; 17(4):249-58. PubMed ID: 12704469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.